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SUMMARY 
Since the prevalence of food allergy and intolerance is increasing in the world, several Food 
Safety Authorities asked to improve the labeling to protect consumers suffering from these 
diseases. New international Directives include alcoholic beverages making mandatory, also for 
this category, the labeling of all ingredients with allergenic effects.  
At present, there is no recognized protocol to perform studies capable to ensure the safety of 
treated wines for allergic subjects. Between processing aids and additives used in enology, egg 
and milk proteins are the most dangerous since the percentage of adults suffering from these 
allergies cannot be ignored (more or less 0.3 % for both allergens). Moreover, other categories, 
such as patients suffering from celiac disease, must be protected by negative effects of toxic 
cereal derivatives. On these bases, the aim of this research was the identification of the most 
suitable approach to evaluate the safety of wines treated with allergenic proteins, considering 
different possible combinations with secondary fining agents. 
 
 
 
RIASSUNTO  
Con l’aumento della prevalenza dei casi di allergie ed intolleranze alimentari, diverse Autorità 
internazionali deputate alla valutazione della Sicurezza Alimentare hanno stilato nuove 
indicazioni relativamente agli obblighi di etichettatura per gli allergeni e ha reso obbligatoria le 
dichiarazioni anche per le bevande alcoliche. Punto critico per questo problema è l’assenza di un 
protocollo riconosciuto per la valutazione della sicurezza delle sostanze allergeniche usate nella 
produzione del vino. Tra gli additivi e i coadiuvanti tecnologici usati in enologia, particolare 
attenzione deve essere rivolta alle proteine di uovo e latte, in quanto il numero di soggetti adulti 
allergici a questi due alimenti non è trascurabile (circa 0.3% per entrambi). Inoltre, nel caso in cui 
si usino proteine da cereali si deve assicurare la protezione dei soggetti celiaci che devono evitare 
prodotti contenenti glutine. Scopo di questa ricerca è la messa a punto di un protocollo 
tossicologico che permetta la valutazione della sicurezza dei vini trattati con sostanze 
allergeniche, tenendo conto dei chiarificanti secondari che possono essere usati in associazione. 
 
 
INTRODUCTION 
 
Since the prevalence of food allergy and intolerance is increasing in the world, several Food 
Safety Authorities asked to improve the labeling to protect consumers suffering from these 
diseases.  New international Directives include alcoholic beverages making mandatory, also for 
this category, the labeling of all ingredients with allergenic effects.  
In wine production, the common practice of clarification consists in adding to the must or wine 
organic or inorganic substances that interact with elements responsible for turbidity and 
organoleptic imbalances. Among organic agents, animal proteins (fish gelatin, egg albumin, and 
milk proteins) are the most widely used because of their excellent fining properties, their ability 
to eliminate tannins, which are responsible for wine astringency, and their comparative 
cheapness. In same case, proteins can be added to wine for their antimicrobial activity;  among 
allergenic proteins, lysozyme (from egg white) is used to prevent malolactic fermentation. 
Milk and egg are responsible for adverse clinical reactions mediated by immunological 
mechanism, known as food allergies. The reported prevalence of milk allergy ranges widely 
according to the diagnostic test used and the geographical area considered. It has been reported to 
be 1.6−2.8% in randomly selected children younger than 2, and even though clinical tolerance is 
frequently acquired by 50−90% of the children under the age of 6, severe milk allergy can persist 
into adulthood (Host, Halken 1990). Similar pattern of sensitization and progressive clinical 
tolerance is observed in children suffering from egg allergy that is normally associated with egg 
white proteins. 
The clinical symptoms, reported also in adult patients, can be classified as immediate or 
delayed reactions, according to the time of onset after the milk or egg ingestion. They range from 
mild to severe and can involve the skin (atopic dermatitis, eczema, lip edema, hives, 
angioedema), gastrointestinal tract (oral syndrome, vomiting, colic, diarrhea or constipation, 
oropharyngeal itching), respiratory tract (cough, wheezing, broncospasm, asthma, dyspnea) and 
other groups of symptoms (insomnia, recurrent otitis media, psychological disturbances). The 
most dangerous clinical event is anaphylaxis, an acute systemic and potentially fatal reaction. 
 
 REASONS FOR DEVELOPING A COMMUN EXPERIMENTAL PROTOCOL 
Both red and white wines are treated with proteins for fining purposes, in other words additives 
and processing aids having allergenic potential are deliberately used in wine production. These 
proteins do not represent a danger for healthy people but they are potentially lethal for those 
patients who are highly sensitized to specific allergens. To minimize the risk for allergic subjects 
suffering from these severe allergic symptoms, producers must control the enological procedures 
carefully. 
At present, there is no recognized international protocol to perform studies capable to ensure the 
safety of treated wines for allergic subjects; as a consequence, the aim of this project is the 
identification of the most suitable approach to evaluate the safety of wines treated with allergenic 
proteins, considering different possible combinations with secondary fining agents. 
Previous experiences of our group showed that red wines are normally characterized by lower 
protein residues, while the residues in white wines are strictly dependent on the specific 
enological practices (Cattaneo et al. 2003a and 2003b).  
From these bases, we suggest some points that should be considered in establishing an 
international research coordinated by OIV.  
 
 
Production 
Wine production, involving the use of allergenic proteins, is a potential risk for allergic patients 
so that the absence of significant residues must be ensured by specific experimental studies aimed 
to identify the most suitable enological procedures, allergen by allergen. The critical points are 
described in Table 1. 
 
 
Table 1 - Critical points in enological practices for wines treated  
with allergenic proteins 
 
Class of factors Parameter Consequences 
Fining agent or additive Allergenic source and 
product characterization 
Presence of one or more proteins 
Stability of proteins could be 
different (loss of activity during 
processes) 
Specific clinical characteristics 
must be considered 
Specific wine characteristics White or red grape 
pH 
Tannin content 
Etc 
 
 
All these factors can modified 
the extent of protein elimination, 
by changing their solubility 
and/or their binding to natural 
substances present in grape 
Enological treatments Secondary fining agents 
Solphites 
Other enological treatments 
(chemical addition and/or 
physical treatments) 
All these factors can be 
responsible for, or interfere with, 
the protein elimination 
 
 
As stated before, protection of allergic subjects requires suitable enological processes, 
experimentally defined for each specific allergen, and the defined practice must be compulsory 
applied by all wine producers to receive exemption from labeling.  
 
 
Analytical Methods 
No suitable enological treatment can be established without a specific, sensitive and reliable 
analytical method. Different analytical approaches can be developed but the most useful 
technique is ELISA test. This method is widely applied in food industry and presents all the 
necessary characteristics described above. The cost is normally acceptable for routine controls 
and trained personnel easily perform it.  
The immunochemical method must be specifically developed for wine and must be reliable 
enough to protect consumers at risk. 
 
 
Clinical Approaches 
All optimized enological practices must be verified by performing clinical studies including Skin 
Prick Test, detection of specific circulating IgEs (RAST, immunoblotting) and double blind 
placebo controlled food (wine) challenge. 
The Skin Prick Test (Figure 1) and the detection of specific IgEs (Figure 2) are not very 
complicate objectives to reach, but different difficulties are associated with the performance of 
oral challenges as shown in Table 2.  
 
 
 
 
 
  
Figure 1 - Skin Prick Test performed with purified fining agent and treated wine 
 
 
 
 
Critical point is the number of allergic subjects who must be enrolled for the oral challenge; in 
fact, (Muraro et al. 2004) according to the definition of hypoallergenic product as established by 
EAACI, 90% of subjects, allergic to any specific allergenic fining agent, should tolerate treateed 
wines. 
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Figure 2   SDS-PAGE (left) and IgE-immunodetection with the serum from a patient allergic to lupin (right) 
of Pinot Noir wine samples, untreated (UW) or treated with lupin protein isolate alone (LW) or 
combined with bentonite (BL) or silica gel (SL).  
 To evaluate nonspecific reactivity, samples clarified with bentonite alone (B) or silica alone (S) were 
also loaded. MK = molecular weight marker solution; Lup = lupin protein isolate. 
 Data from Cattaneo et al, 2003b. 
 
 
 
Table 2 - Critical points and limitations in performing oral challenges 
 
Topic Comments 
Patient included Allergy is more frequent in childhood but 
children cannot be enrolled in studies where 
wine administration is necessary 
Number of patients Adult patients are relatively few and it is 
difficult to enroll the number necessary to 
reach statistical significance (see text) 
Cost Patients must be hospitalized twice (day 
hospital) for several hours, to perform 
challenges with treated and control wines 
 
 
 
CONCLUSIONS 
Food allergy is a frequent pathology in children but its prevalence decreases in adult people, who 
consume alcoholic beverages. Even though, the figure of adult patients suffering from severe 
allergic reactions is relatively low, high level of control must be asked to wine producers if 
suitable dossiers must be presented to International Toxicological Committees in order to obtain 
the exemption from labeling of fining agents or additives. On these bases, the best strategy is the 
definition of international collaborative studies to define the best enological procedure to 
minimize dangerous residues in treated wines. 
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